IL6 and breast carcinoma: Furthermore, evidence has shown that GPX8 maintains an aggressive breast cancer phenotype by regulating the interleukin 6 (IL-6)/JAK/STAT3 signaling pathway [57], which is hyperactivated in many different malignancies and is generally linked to a poor prognosis [61].